1. Search Result
Search Result
Targets Recommended: CRISPR/Cas9
Results for "


" in MCE Product Catalog:
Cat. No. Product Name Target Research Areas
  • HY-P99015

    TNF Receptor Cancer
    Dacetuzumab (SGN-40) is a humanized IgG1, anti-CD40 monoclonal antibody with anti-lymphoma activity. Dacetuzumab kills tumor cells via immune effector functions (antibody-dependent cellular cytotoxicity and phagocytosis [ADCC/ADCP]). Dacetuzumab ((SGN-40) can be used for multiple myeloma research.